We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Hologic to Acquire Mammography Technology

By HospiMedica staff writers
Posted on 05 Jul 2005
Print article
Hologic (Bedford, MA, USA), a provider of diagnostic imaging and digital imaging systems geared toward women's health, has entered into a definitive agreement to acquire the intellectual property of Fischer Imaging Corp. (Denver, CO, USA) related to its mammography business and products, including the rights to its SenoScan digital mammography and MammoTest stereotactic breast biopsy systems. Fischer Imaging designs, manufactures, and markets medical imaging systems for the diagnosis of breast cancer.

Hologic, under the terms of the agreement, has agreed to purchase the mammography intellectual property for a cash purchase price of US$32 million. "Expanding our market share in women's health is a key element in the growth of our company,” said Jack Cumming, chairman and CEO, Hologic. "The acquisition of these technologies is consistent with the company's strategy of looking to the future and building upon our established technology road map. Through a planned approach of ongoing technological advances and acquiring some of the best intellectual property in the field, Hologic has been able to offer innovative solutions to our customers. We believe this acquisition provides us with additional technical capabilities and customer relationships to further solidify our position of strength in the growing mammography market.”





Related Links:
Hologic
Fischer Imaging
Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Examination Light
Avante Vista Flex
New
Hemodynamic Monitoring Sensor
FloTrac

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.